Clinical trialNCT00808808CompletedObservational

Assessing Choice in the Employer Setting (ACES) Study

SponsorMedImmune LLCEnrollment4,411Healthy

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to determine, among adults and in the total population, the effects of offering a choice of FluMist or trivalent inactivated vaccine (TIV) in the employer setting when compared to a control group.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Seth Toback, M.D.
MedImmune LLC
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

47 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Facility name not stated
Chatsworth, California, United States
Facility name not stated
Novato, California, United States
Facility name not stated
Sacramento, California, United States
Facility name not stated
Sacramento, California, United States
Facility name not stated
San Francisco, California, United States
Facility name not stated
Santa Clara, California, United States
Facility name not stated
Santa Monica, California, United States
Facility name not stated
Sunnyvale, California, United States
Facility name not stated
Thousand Oaks, California, United States
Facility name not stated
Boulder, Colorado, United States
Facility name not stated
Denver, Colorado, United States
Facility name not stated
Washington D.C., District of Columbia, United States
Facility name not stated
Tampa, Florida, United States
Facility name not stated
Hebron, Kentucky, United States
Facility name not stated
La Grange, Kentucky, United States
Facility name not stated
Lawrenceburg, Kentucky, United States
Facility name not stated
Louisville, Kentucky, United States
Facility name not stated
Louisville, Kentucky, United States
Facility name not stated
Annapolis, Maryland, United States
Facility name not stated
Baltimore, Maryland, United States
Facility name not stated
Baltimore, Maryland, United States
Facility name not stated
Baltimore, Maryland, United States
Facility name not stated
Baltimore, Maryland, United States
Facility name not stated
Baltimore, Maryland, United States
Facility name not stated
Baltimore, Maryland, United States
Facility name not stated
Calverton, Maryland, United States
Facility name not stated
Cockeysville, Maryland, United States
Facility name not stated
Columbia, Maryland, United States
Facility name not stated
Columbia, Maryland, United States
Facility name not stated
Crofton, Maryland, United States
Facility name not stated
Hanover, Maryland, United States
Facility name not stated
Hunt Valley, Maryland, United States
Facility name not stated
Laurel, Maryland, United States
Facility name not stated
Sparks, Maryland, United States
Facility name not stated
Basking Ridge, New Jersey, United States
Facility name not stated
Larwenceville, New Jersey, United States
Facility name not stated
Morristown, New Jersey, United States
Facility name not stated
Albuquerque, New Mexico, United States
Facility name not stated
Rochester, New York, United States
Facility name not stated
Rochester, New York, United States

7 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Choice of TIV or FluMist with baseline advertisementControl - Usual care offering TIV only with baseline advertisement

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Sept 2008
Primary completion: 30 Nov 2008
Completion: 31 Dec 2008
Last update posted: 20 Nov 2013
Registered enrollment: 4,411
Registry id: NCT00808808

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.